$VREX Balance Sheet | Understand Stock

$VREX

$18.46 +$0.00 (0.0%) After hours

$VREX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD, except per-share amounts

	Q3 FY2026 As of Jul 3, 2026	Q2 FY2026 As of Apr 3, 2026	Q1 FY2026 As of Jan 2, 2026	Q4 FY2025 As of Oct 3, 2025	Q3 FY2025 As of Jul 4, 2025	Q2 FY2025 As of Apr 4, 2025	Q1 FY2025 As of Jan 3, 2025	Q4 FY2024 As of Sep 27, 2024	Q3 FY2024 As of Jun 28, 2024	Q2 FY2024 As of Mar 29, 2024	Q1 FY2024 As of Dec 29, 2023	Q4 FY2023 As of Sep 29, 2023	Q3 FY2023 As of Jun 30, 2023	Q2 FY2023 As of Mar 31, 2023	Q1 FY2023 As of Dec 30, 2022	Q4 FY2022 As of Sep 30, 2022	Q3 FY2022 As of Jul 1, 2022	Q2 FY2022 As of Apr 1, 2022	Q1 FY2022 As of Dec 31, 2021	Q4 FY2021 As of Oct 1, 2021
Assets
Current assets:
Cash and cash equivalents
Marketable securities
Accounts receivable, net of allowance for credit losses of $1.9 million and $2.1 million at July 3, 2026 and October 3, 2025, respectively
Inventories, net
Prepaid expenses and other current assets
Total current assets
Property, plant, and equipment, net
Goodwill
Intangible assets, net
Investments in privately-held companies
Deferred tax assets
Operating lease assets
Restricted cash
Other assets
Total assets
Liabilities and stockholders' equity
Current liabilities:
Accounts payable
Accrued liabilities and other current liabilities
Current operating lease liabilities
Current maturities of long-term debt, net
Deferred revenues
Total current liabilities
Long-term debt, net
Deferred tax liabilities
Operating lease liabilities
Other long-term liabilities
Total liabilities
Preferred stock, $0.01 par value: 20,000,000 shares authorized, none issued
Common stock, $.01 par value: 150,000,000 shares authorized, shares issued and outstanding: 40,085,126 and 39,435,830 at September 30, 2022 and October 1, 2021, respectively
Stockholders' equity:
Preferred stock, $0.01 par value: 20,000,000 shares authorized, none issued
Common stock, $0.01 par value: 150,000,000 shares authorized; Shares issued and outstanding: TBU and 41,689,672 at July 3, 2026 and October 3, 2025, respectively
Additional paid-in capital
Accumulated other comprehensive loss
Retained earnings (accumulated deficit)
Total Varex stockholders' equity
Noncontrolling interests
Total stockholders' equity
Total liabilities and stockholders' equity

Comments